Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > There is no Bull Thesis on this Stock on any Forum
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by RodneyCameronon Mar 02, 2017 2:15pm
59 Views
Post# 25921316

RE:RE:There is no Bull Thesis on this Stock on any Forum

RE:RE:There is no Bull Thesis on this Stock on any ForumThe stock could tank like it has been doing and if any one listened to you they would be underwater.

Oh wait...  never mind,  Baggie.


CytochromeP wrote:

BrandonFielding

Brandon FieldingJoined Dec 03, 2016

 






I always ask BA comerce students fresh out of university to manage my portfolios for me, what could go wrong?


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities